Vanguard Group Inc Rani Therapeutics Holdings, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RANI
# of Institutions
41Shares Held
2.96MCall Options Held
32.8KPut Options Held
4.2K-
Nan Fung Group Holdings LTD Central, K3494KShares$1.04 Million2.18% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$946,3180.11% of portfolio
-
United Services Automobile Association San Antonio, TX312KShares$658,5200.03% of portfolio
-
Geode Capital Management, LLC Boston, MA151KShares$318,0480.0% of portfolio
-
Stifel Financial Corp St. Louis, MO135KShares$284,0480.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $51.7M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...